Maternal sepsis is a time-critical complication in which infection triggers organ dysfunction during pregnancy, labor, birth, or the postpartum period. Its early presentation can resemble normal physiological changes of pregnancy, making clinical judgment especially important when symptoms are subtle or rapidly evolving.
The peripartum period brings several potential infection sources, including the uterus, urinary tract, respiratory system, surgical wounds, intravenous access sites, and breasts. Group A streptococcal infection, intra-amniotic infection, pyelonephritis, endometritis, and postoperative wound infection can all progress quickly. A reliable response depends on recognizing deterioration rather than waiting for a perfect diagnosis.
Perinatal medicine has long emphasized coordinated care across obstetrics, midwifery, neonatology, anesthesia, emergency medicine, microbiology, and critical care. The educational focus of the FAOPS 2020 congress site reflects that multidisciplinary setting, where maternal and neonatal outcomes are considered together.
Pregnancy changes cardiovascular, respiratory, renal, and hematological physiology. Heart rate is often higher than the non-pregnant baseline, plasma volume is expanded, and white blood cell counts may rise during labor. These adaptations can conceal early infection or make standard adult thresholds less reliable.
A person with sepsis may initially report feeling unusually unwell, weak, breathless, confused, or unable to care for the baby. Fever may be absent, especially in severe infection or after antipyretic treatment. Tachycardia, hypotension, reduced urine output, altered mental status, increasing oxygen needs, and abnormal skin perfusion should therefore be interpreted as a pattern rather than isolated findings.
Clinicians should also account for the postpartum trajectory. Pain, lochia, fatigue, and mild temperature variation may be expected after birth, yet new or worsening symptoms require reassessment. A deterioration several days after delivery can be just as serious as an infection diagnosed during labor.
Assessment begins with an immediate review of airway, breathing, circulation, disability, and exposure, followed by a focused search for the infectious source. Record vital signs promptly and repeat them frequently when abnormalities are present. Compare findings with the patient’s baseline and look for trends, such as a rising pulse, falling blood pressure, declining oxygen saturation, or progressively reduced urine production.
Potential warning signs include rigors, fever or hypothermia, severe abdominal or pelvic pain, uterine tenderness, foul-smelling vaginal discharge, dysuria, flank pain, productive cough, breast inflammation, wound separation, or pain out of proportion to examination findings. A rapidly spreading soft-tissue infection may have minimal visible skin change early on.
The following framework supports escalation without replacing local protocols, obstetric assessment, or critical care guidance:
| Clinical finding | Immediate concern | Practical response |
|---|---|---|
| New confusion, collapse, severe breathlessness, or marked weakness | Organ dysfunction or impending instability | Activate emergency escalation and obtain senior help |
| Persistent tachycardia, hypotension, delayed capillary refill, or cool extremities | Circulatory compromise | Establish monitoring, intravenous access, and resuscitation |
| Low oxygen saturation or increasing work of breathing | Respiratory failure, pneumonia, pulmonary edema, or embolic disease | Provide oxygen as indicated and investigate urgently |
| Oliguria or rising creatinine | Renal hypoperfusion or organ injury | Measure urine output, assess circulation, and involve critical care |
| Uterine tenderness, offensive lochia, or pelvic pain | Intrauterine or postpartum infection | Take cultures, begin appropriate antimicrobials, and assess source control |
| Wound pain, discoloration, crepitus, or rapidly progressive swelling | Necrotizing soft-tissue infection | Arrange urgent surgical review and broad-spectrum treatment |
Laboratory tests can support the assessment but should not delay treatment. Blood cultures, full blood count, renal and liver profiles, coagulation studies, lactate where locally recommended, urinalysis, urine culture, and relevant imaging may help define severity and source. A normal white cell count or modest lactate level does not exclude serious infection.
Once maternal infection with organ dysfunction is suspected, call for senior obstetric and anesthetic support. Notify the neonatal team when birth may be imminent or fetal compromise is present. A clear verbal declaration, such as “suspected maternal sepsis with possible organ dysfunction,” helps the entire team understand the urgency.
Insert suitable intravenous access, obtain blood samples and cultures, and begin fluid therapy when clinically indicated. Fluids should be individualized, particularly in patients with preeclampsia, cardiac disease, renal impairment, pulmonary edema, or hemorrhage. Reassess blood pressure, respiratory status, mental state, skin perfusion, and urine output after each intervention.
Administer broad-spectrum intravenous antibiotics according to local resistance patterns, allergy history, pregnancy and breastfeeding considerations, and the likely source. The first dose should not be postponed while waiting for imaging or definitive culture results. Involve microbiology or infectious diseases specialists when the source is unclear, infection is severe, resistant organisms are possible, or treatment is not producing improvement.
If hypotension persists after appropriate fluid assessment, critical care consultation is urgent because vasopressor therapy and invasive monitoring may be required. Oxygenation, glucose, temperature, analgesia, and venous thromboembolism risk also deserve active management. Documentation should include the time of recognition, cultures, antibiotic administration, fluid balance, consultations, and response to treatment.
Antibiotics alone may be insufficient when infected tissue, retained products, an abscess, an infected hematoma, or a necrotic wound remains. Source control can include drainage, removal of infected material, debridement, removal of an infected device, or operative management. The decision should be made with obstetrics, surgery, anesthesia, radiology, and critical care as appropriate.
Delivery is not automatically required for every maternal infection. The need for birth depends on gestational age, fetal condition, labor progress, the suspected source, maternal physiology, and whether delivery contributes to source control. Intra-amniotic infection may influence decisions about timing and mode of birth, while a urinary infection or pneumonia may be treated without immediate delivery if the mother and fetus remain stable.
When urgent birth is necessary, preparation should include blood availability, anesthesia planning, neonatal resuscitation, antibiotic coordination, and a clear postoperative destination. Maternal stabilization remains central, but fetal monitoring and neonatal preparation should occur in parallel. A deteriorating mother may need transfer to a higher-acuity setting even when the birth plan is still being determined.
Postpartum patients require the same urgency. Endometritis, wound infection, mastitis, urinary infection, and pelvic abscess can emerge after discharge. Follow-up instructions should identify warning signs and provide a direct route back to maternity or emergency services, particularly for people who face transport, language, financial, or social barriers.
Sepsis care often fails at transitions: triage to labor ward, operating theatre to recovery, hospital to home, or maternity services to emergency care. A structured handover should state the suspected source, vital-sign trajectory, organ dysfunction, treatment already given, pending tests, allergies, relevant pregnancy history, and the next clinical decision.
Team members should use closed-loop communication for high-risk actions. The person ordering cultures confirms that they were collected; the antibiotic administrator records the exact time; the receiving clinician repeats the escalation plan. This reduces ambiguity during a rapidly changing emergency.
Families should receive clear, compassionate explanations about the suspected infection, treatments, investigations, and possible effects on pregnancy or the newborn. If the patient becomes critically ill, identify a family contact and explain changes in location or care level. Communication remains part of safe treatment, especially when procedures, operative delivery, or intensive care may be required.
The wider circumstances of care also matter. During periods of restricted visiting or social distancing, hospitals need dependable remote communication, interpreter access, and discharge pathways. Guidance on high-risk pregnancy care illustrates why continuity and communication must be designed into perinatal services rather than improvised during a crisis.
A written maternal sepsis pathway should be visible, current, and adapted to the facility’s resources. It should define screening triggers, escalation contacts, antibiotic choices, culture procedures, fluid and vasopressor guidance, critical care referral, source-control pathways, and postpartum follow-up. Policies need regular review as local microbiology data, national guidance, and available treatments change.
Readiness improves when teams rehearse realistic cases. Simulation can cover a febrile laboring patient, a postpartum patient with septic shock, an infected cesarean wound, or a patient whose initial symptoms are nonspecific. Debriefing should examine delays in recognition, equipment access, prescribing, laboratory processing, communication, and transfer.
Practical recommendations include:
Quality improvement should examine both outcomes and process measures. Mortality and intensive care admission are important, but delays in antibiotics, missed deterioration, unplanned readmission, and incomplete handovers can reveal preventable weaknesses earlier. Reviewing cases without blame encourages staff to report near misses and identify system changes.
Maternal sepsis recognition and management in the peripartum period require disciplined attention to change, early treatment, and coordinated escalation. The most effective systems do not depend on one score or one professional group. They combine clinical observation, timely investigations, appropriate antimicrobials, physiological support, source control, fetal and neonatal planning, and respectful communication.
Every maternity service can translate these principles into a local pathway, test it through simulation, and measure whether care reaches patients quickly. Clinicians, educators, and perinatal researchers can use congress resources and multidisciplinary learning to strengthen protocols across hospitals and regions. Begin with the next team briefing: agree on the warning signs, escalation route, antibiotic process, and responsibilities before the next emergency occurs.